These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 23492735)
1. Delayed small bowel transit in children with cystic fibrosis and pancreatic insufficiency. Rovner AJ; Schall JI; Mondick JT; Zhuang H; Mascarenhas MR J Pediatr Gastroenterol Nutr; 2013 Jul; 57(1):81-4. PubMed ID: 23492735 [TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal transit times and motility in patients with cystic fibrosis. Hedsund C; Gregersen T; Joensson IM; Olesen HV; Krogh K Scand J Gastroenterol; 2012 Sep; 47(8-9):920-6. PubMed ID: 22746323 [TBL] [Abstract][Full Text] [Related]
3. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT. Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537 [TBL] [Abstract][Full Text] [Related]
4. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency. Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038 [TBL] [Abstract][Full Text] [Related]
5. Addition of small-bowel transit scintigraphy to gastric emptying for assessment of patients with upper gastrointestinal symptoms. Maurer AH; Yu D; Lu X; Dadparvar S; Kamat BH; Shahsavari D; Parkman HP Neurogastroenterol Motil; 2021 Feb; 33(2):e13987. PubMed ID: 32996253 [TBL] [Abstract][Full Text] [Related]
6. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency. Kuhn RJ; Gelrud A; Munck A; Caras S Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085 [TBL] [Abstract][Full Text] [Related]
7. Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study. Graff GR; McNamara J; Royall J; Caras S; Forssmann K Clin Drug Investig; 2010; 30(6):351-64. PubMed ID: 20441244 [TBL] [Abstract][Full Text] [Related]
8. Lingual lipase in cystic fibrosis. Quantitation of enzyme activity in the upper small intestine of patients with exocrine pancreatic insufficiency. Abrams CK; Hamosh M; Hubbard VS; Dutta SK; Hamosh P J Clin Invest; 1984 Feb; 73(2):374-82. PubMed ID: 6699170 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study. Colombo C; Fredella C; Russo MC; Faelli N; Motta V; Valmarana L; Longo L; D'Orazio C Pancreas; 2009 Aug; 38(6):693-9. PubMed ID: 19531972 [TBL] [Abstract][Full Text] [Related]
10. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study. Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712 [TBL] [Abstract][Full Text] [Related]
11. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. De Boeck K; Weren M; Proesmans M; Kerem E Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171 [TBL] [Abstract][Full Text] [Related]